The purpose of this study is to investigate a new form of hormonal contraception called LevoCept® as a possible long-acting and reversible hormonal IUD. LevoCept® is an investigational product that is being developed as a possible new method of birth control. An investigational product is one that has not yet been approved by the Food and Drug Administration (FDA) for sale in the United States, this study tests its effectiveness in preventing pregnancy. This method of birth control is similar to currently approved hormonal IUDs like the MIRENA® (Bayer), LILETTA® (Allergan), and SKYLA® (Bayer). The LevoCept® IUD is different because it is made of a more flexible material with a spring-type shape, which conforms to the shape of your uterus with the goal of providing comfort during device insertion.
- You are between the ages of 18 and 45
- You have regular menstrual cycles every 21-35 days
- You are in good general health
- You have a mobile device to keep a daily diary
Qualified participants may be compensated up to $750 for time and travel and receive $1 for every daily diary entry completed.
Whom do I contact for additional information?
To find out more information and to learn if you are qualified to participate, fill out the online form or call the Women’s Health Research Unit confidential recruitment line at 503-494-3666 or email us at email@example.com.
Complete the online form” link will lead to Contact Form page http://www.ohsu.edu/xd/health/services/women/clinical-trials/contact-us.cfm